Caribou Biosciences, Inc. (CRBU) NASDAQ
2.43
+0.07(+2.97%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.43
+0.07(+2.97%)
Currency In USD
| Market Cap | 148.49M |
| Enterprise Value | 163.36M |
| P/E Ratio | -1.75 |
| PEG Ratio | -0.16 |
| Price/Sales Ratio | 21.51 |
| Price/Book Ratio | 2.28 |
| Enterprise/Revenue | 22.84 |
| Enterprise/EBITDA | -2.2 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -11.89 |
| Operating Margin | -11.76 |
| Return On Assets | -0.89 |
| Return On Equity | -1 |
| Revenue | 11.16M |
| Revenue/Share | 0.12 |
| Gross Profit | 7.51M |
| EBITDA | -132.55M |
| Net Income | -148.13M |
| Diluted EPS | -1.59 |
| Total Cash | 117.63M |
| Total Cash/Share | 1.23 |
| Total Debt | 26.95M |
| Total Debt/Equity | 0.26 |
| Current Ratio | 6.22 |
| Book Value Per Share | 1.06 |
| 52-Week Change | 149.26 |
| 52-Week High | 3.54 |
| 52-Week Low | 0.96 |
| Moving Average 50 Days | 2.04 |
| Moving Average 200 Days | 1.95 |
| Average Volume | 1.44M |
| Shares Outstanding | 99.18M |
| % Held by Institutions | 40.51 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |